|
|
viii | |
Foreword |
|
ix | |
|
1 Introduction to the WHO Reporting System for Pancreati-cobiliary Cytopathology |
|
|
1 | (10) |
|
|
2 | (2) |
|
The role of pancreaticobiliary cytopathology |
|
|
4 | (1) |
|
Integration of clinical, radiological, and key FNAB cytopathological features with ancillary testing in a diagnostic approach |
|
|
5 | (1) |
|
Diagnostic categories and report structure |
|
|
6 | (3) |
|
Risk of malignancy and management recommendations |
|
|
9 | (2) |
|
2 Pancreaticobiliary cytopathology techniques |
|
|
11 | (20) |
|
Sampling methods and tissue triage FNAB techniques and specimen management for solid pancreatic masses |
|
|
12 | (1) |
|
FNAB techniques and specimen management for pancreatic cysts |
|
|
13 | (1) |
|
FNAB techniques and specimen management for bile duct brushings |
|
|
14 | (2) |
|
Percutaneous FNAB and specimen management |
|
|
16 | (1) |
|
|
17 | (1) |
|
Ancillary testing Introduction: The role of ancillary testing |
|
|
18 | (1) |
|
|
19 | (4) |
|
|
23 | (3) |
|
|
26 | (3) |
|
Biochemical testing of cyst fluid |
|
|
29 | (2) |
|
3 Diagnostic category: Insufficient/Inadequate/Non-diag-nostic |
|
|
31 | (6) |
|
|
32 | (1) |
|
|
32 | (1) |
|
Discussion and background |
|
|
33 | (2) |
|
Risk of malignancy and management recommendations |
|
|
35 | (1) |
|
|
36 | (1) |
|
4 Diagnostic category: Benign / Negative for malignancy |
|
|
37 | (34) |
|
|
38 | (1) |
|
|
38 | (1) |
|
Discussion and background |
|
|
39 | (1) |
|
Risk of malignancy and management recommendations |
|
|
40 | (1) |
|
Benign non-neoplastic processes Normal pancreatic and biliary parenchyma and contaminants |
|
|
41 | (3) |
|
|
44 | (2) |
|
|
46 | (2) |
|
|
48 | (2) |
|
Groove/paraduodenal pancreatitis |
|
|
50 | (2) |
|
Autoimmune and lgG4-related pancreatitis |
|
|
52 | (3) |
|
|
55 | (2) |
|
|
57 | (2) |
|
Splenule (accessory spleen) |
|
|
59 | (2) |
|
Benign neoplastic processes Serous cystadenoma |
|
|
61 | (3) |
|
|
64 | (1) |
|
|
65 | (1) |
|
Other rare benign neoplasms |
|
|
66 | (1) |
|
|
67 | (4) |
|
5 Diagnostic category: Atypical |
|
|
71 | (6) |
|
|
72 | (1) |
|
|
72 | (1) |
|
Discussion and background |
|
|
73 | (2) |
|
Risk of malignancy and management recommendations |
|
|
75 | (1) |
|
|
76 | (1) |
|
6 Diagnostic category: Pancreaticobiliary neoplasm, low-risk/grade |
|
|
77 | (16) |
|
|
78 | (1) |
|
|
78 | (1) |
|
Discussion and background |
|
|
79 | (1) |
|
Risk of malignancy and management recommendations |
|
|
80 | (1) |
|
Specific lesions Pancreatic intraepithelial neoplasia, low-grade |
|
|
81 | (2) |
|
Biliary intraepithelial neoplasia, low-grade |
|
|
83 | (2) |
|
Pancreatic intraductal papillary mucinous neoplasm, low-grade |
|
|
85 | (2) |
|
Intraductal papillary neoplasm of the bile duct, low-grade |
|
|
87 | (1) |
|
Mucinous cystic neoplasm, low-grade |
|
|
88 | (2) |
|
Other lesions (including spindle cell tumours) |
|
|
90 | (1) |
|
|
91 | (2) |
|
7 Diagnostic category: Pancreaticobiliary neoplasm, high-risk/grade |
|
|
93 | (22) |
|
|
94 | (1) |
|
|
94 | (1) |
|
Discussion and background |
|
|
95 | (1) |
|
Risk of malignancy and management recommendations |
|
|
96 | (1) |
|
Specific lesions Pancreatic intraepithelial neoplasia, high-grade |
|
|
97 | (2) |
|
Biliary intraepithelial neoplasia, high-grade |
|
|
99 | (2) |
|
Pancreatic intraductal papillary mucinous neoplasm, high-grade |
|
|
101 | (3) |
|
Intraductal papillary neoplasm of the bile duct, high-grade |
|
|
104 | (2) |
|
Mucinous cystic neoplasm, high-grade |
|
|
106 | (2) |
|
Intraductal oncocytic papillary neoplasm |
|
|
108 | (2) |
|
Intraductal tubulopapillary neoplasm |
|
|
110 | (2) |
|
|
112 | (3) |
|
8 Diagnostic category: Suspicious for malignancy |
|
|
115 | (6) |
|
|
116 | (1) |
|
|
116 | (1) |
|
Discussion and background |
|
|
117 | (2) |
|
Risk of malignancy and management recommendations |
|
|
119 | (1) |
|
|
120 | (1) |
|
9 Diagnostic category: Malignant |
|
|
121 | (48) |
|
|
122 | (1) |
|
|
122 | (1) |
|
Discussion and background |
|
|
123 | (1) |
|
Risk of malignancy and management recommendations |
|
|
124 | (2) |
|
Specific lesions Cholangiocarcinoma |
|
|
126 | (4) |
|
Pancreatic ductal adenocarcinoma |
|
|
130 | (9) |
|
Pancreatic acinar cell carcinoma |
|
|
139 | (3) |
|
|
142 | (4) |
|
|
146 | (2) |
|
|
148 | (3) |
|
Solid pseudopapillary neoplasm |
|
|
151 | (5) |
|
|
156 | (3) |
|
Metastases to the pancreas |
|
|
159 | (4) |
|
Other lesions (including spindle cell tumours) |
|
|
163 | (3) |
|
|
166 | (3) |
|
10 Management recommendationsfor each diagnostic category |
|
|
169 | (18) |
|
|
170 | (1) |
|
Insufficient/Inadequate/Non-diagnostic |
|
|
171 | (1) |
|
Benign / Negative for malignancy |
|
|
172 | (1) |
|
|
173 | (1) |
|
Pancreaticobiliary neoplasm, low-risk/grade |
|
|
174 | (2) |
|
Pancreaticobiliary neoplasm, high-risk/grade |
|
|
176 | (2) |
|
Suspicious for malignancy |
|
|
178 | (1) |
|
|
179 | (2) |
|
|
181 | (2) |
|
|
183 | (2) |
|
|
185 | (2) |
References |
|
187 | (16) |
Subject Index |
|
203 | (2) |
Previous volumes in the series |
|
205 | |